Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis

Clinical Nephrology

Volumn 73, Issue 5, 2010, Pages 354-359

  Yuan, M ^a   Zou, J ^a   Zhang, X ^a   Liu, H ^a   Teng, J ^a   Zhong, Y ^a   Ding, X ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Glucocorticoids; Idiopathic membranoproliferative glomerulonephritis; Mycophenolate mofetil; Proteinuria

Indexed keywords

ALBUMIN; BENAZEPRIL; CREATININE; GLUCOCORTICOID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; VALSARTAN;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFECTION; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LEUKOCYTE DISORDER; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MICROSCOPY; PROTEINURIA; TREATMENT DURATION; URINARY EXCRETION;

EID: 77951663701     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP73354     Document Type: Article

References (14)

1. Stratta P, Segoloni GP, Canavese Cet al. Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis. 1996; 27: 631-639. (Pubitemid 26135834)
2. Simon P, Ramee MP, Autuly V et al. Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int. 1993; 46: 1192-1198.
3. Harmankaya Ö, Bastürk T, Öztürk Y, et al. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis Type I. Int Urol Nephrol. 2001; 33: 583-587.
4. Karim MY, Alba P, Cuadrado MJ, et al. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology. 2002; 41: 876-882.
5. Choi MJ, Eustace JA,Gimenez et al. Mycophenolate mofetil treatment of primary glomerular disease. Kidney Int. 2002; 61: 1089-1114.
6. Grcevska L, Polenakovic M. Mycophenolate mofetil in the treatment of glomerular diseases. Prilozi. 2007; 28: 57-68.
7. Sahin GM, Sahin S, Kantarci G. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies. Nephrology (Carlton). 2007; 12: 285-288. (Pubitemid 46718198)
8. Jones G, Juszczak M, Kingdom E, et al.Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant. 2004; 19: 3160-3164. (Pubitemid 40057644)
9. Tarshish P, Bernstein J, Tobin JN et al. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone-a report of the International Study of Kidney Disease in Children. Pediatr Nephrol. 1992; 6: 123-130.
10. Zhao-Long WU, Min YUAN et al. Clinicopathology and long-term follow-up of idiopathic membranoproliferative glomerulonephritis. Hong Kong Journal of Nephrology. 2000; 2: 44-49.
11. Faedda R, Satta A, Tanda F et al. Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron. 1994; 67: 59-65.
12. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immuno Pharmacology. 2000; 47: 85-118.
13. Adu D, Cross J, Jayne DR. Treatment of systemic lupus erythematosus with mycophenolate mofetil. Lupus. 2001; 10: 203-208. (Pubitemid 32410078)
14. Badid C, Vincent M, McGregor B et al. Mycophenolate mofetil reduce myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int. 2000; 58: 51-61.